[1]刘 杰,闵林玲,潘 金,等.经颈静脉肝内门腔静脉分流术与经皮肝穿刺胃冠状静脉栓塞术治疗肝硬化食管胃底静脉曲张破裂出血疗效对比研究[J].陕西医学杂志,2023,52(9):1191-1195.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.017]
　LIU Jie,MIN Linling,PAN Jin,et al.Comparative study of TIPS and PTVE in treatment of esophageal and gastric varices bleeding in liver cirrhosis[J].,2023,52(9):1191-1195.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.017]
点击复制

经颈静脉肝内门腔静脉分流术与经皮肝穿刺胃冠状静脉栓塞术治疗肝硬化食管胃底静脉曲张破裂出血疗效对比研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年9期
页码:
1191-1195
栏目:
临床研究
出版日期:
2023-09-05

文章信息/Info

Title:
Comparative study of TIPS and PTVE in treatment of esophageal and gastric varices bleeding in liver cirrhosis
作者:
刘 杰1; 闵林玲2; 潘 金1; 母燕玲1; 姚 勇1
(1.遂宁市中心医院消化内科,四川 遂宁 629000; 2.遂宁市中心医院急症科,四川 遂宁 629000)
Author(s):
LIU Jie; MIN Linling; PAN Jin; MU Yanling; YAO Yong
(Department of Gastroenterology,Suining Central Hospital,Suining 629000,China)
关键词:
肝硬化;  食管胃底静脉曲张破裂出血;  经颈静脉肝内门腔静脉分流术;  经皮肝穿刺胃冠状静脉栓塞术;  门脉系统;  血流动力学;  肝功能
Keywords:
Liver cirrhosis;  Esophageal and gastric varices bleeding;  Transjugular intrahepatic portosystemic shunt;  Percutaneous transhepatic varicral embolization;  Portal venous system;  Hemodynamics;  Liver function
分类号:
R 543.6
DOI:
DOI:10.3969/j.issn.1000-7377.2023.09.017
文献标志码:
A
摘要:
目的:比较经颈静脉肝内门腔静脉分流手术(TIPS)与经皮肝穿刺胃冠状静脉栓塞术(PTVE)治疗肝硬化食管胃底静脉曲张破裂出血(EGVB)的疗效。方法:选取肝硬化EGVB患者135例,将采用TIPS治疗的患者纳入TIPS组(93例),将采用PTVE治疗的患者纳入PTVE组(42例)。于术前和术后1个月,比较两组患者食管胃底静脉曲张程度,外周血白细胞(WBC)、红细胞(RBC)和血小板(PLT),门脉系统血流动力学指标[门静脉直径(PVD)、门静脉流速(PVV)和脾静脉流速(SVV)]以及肝功能指标[血清谷草转氨酶(AST)、总胆红素(TBIL)和白蛋白(ALB)]。比较两组患者术后1个月并发症发生情况。结果:术前,两组患者食管胃底静脉曲张程度,外周血WBC、RBC和PLT,PVD、PVV和SVV,以及AST、TBIL和ALB比较,差异无统计学意义(均P>0.05)。术后1个月,两组食管胃底静脉曲张程度较术前改善,且TIPS组患者食管胃底静脉曲张程度较PTVE组减轻(均P<0.05); 两组患者WBC和PLT水平较术前升高,且TIPS组高于PTVE组(均P<0.05); 两组患者RBC比较差异无统计学意义(均P>0.05); 两组患者PVD较术前降低,PVV和SVV较术前升高,且TIPS组PVD低于PTVE组,PVV和SVV高于PTVE组(均P<0.05); 两组患者肝功能指标比较差异无统计学意义(均P>0.05); TIPS组并发症总发生率低于PTVE组(P<0.05)。结论:肝硬化EGVB患者采用TIPS进行治疗,可有效减轻食管胃底静脉曲张程度,降低门静脉压力,提高患者外周血WBC和PLT,改善门脉系统血流动力学,且对患者肝功能影响较小,安全性较高。
Abstract:
Objective:To compare the efficacy of transjugular intrahepatic portosystemic shunt(TIPS)and percutaneous transhepatic varicral embolization(PTVE)in the treatment of esophageal and gastric varices bleeding(EGVB).Methods:A total of 135 patients with liver cirrhosis-induced EGVB were selected.Patients treated with TIPS were included in the TIPS group(93 cases),and patients treated with PTVE were included in the PTVE group(42 cases).Before operation and 1 month after operation,the severity of esophageal and gastric varices,peripheral blood WBC,RBC and PLT,Hemodynamic parameters of the portal vein system(portal vein diameter [PVD],portal vein flow velocity [PVV] and splenic vein flow velocity [SVV]),liver function parameters(serum aspartate aminotransferase [AST],total bilirubin [TBIL] and albumin [ALB])were compared between the two groups.The incidence of complications 1 month after operation was compared between the two groups.Results:There were no significant differences in the severity of esophageal and gastric varices,peripheral blood WBC,RBC and PLT,PVD,PVV and SVV,AST,TBIL and ALB between the two groups before operation(all P>0.05).One month after operation,the severity of esophageal and gastric varices in the two groups was improved compared with that before operation,and the severity of esophageal and gastric varices in the TIPS group was lighter than that in the PTVE group(all P<0.05); WBC and PLT levels in the two groups were higher than those before operation,and those in the TIPS group were higher than those in the PTVE group(all P<0.05),but there was no statistically significant difference in RBC between the two groups(P>0.05); PVD was lower than that before operation,PVV and SVV were higher than those before operation in the two groups,and PVD in the TIPS group was lower than that in the PTVE group,PVV and SVV in the TIPS group were higher than those in the PTVE group(all P<0.05); there were no statistically significant differences in liver function indexes between the two groups(all P>0.05).The total incidence of complications in the TIPS group was lower than that in the PTVE group(P<0.05).Conclusion:TIPS in the treatment of cirrhosis-induced EGVB can effectively reduce the severity of esophageal and gastric varices,reduce portal vein pressure,improve peripheral blood WBC and PLT,and improve portal vein system hemodynamics,with little effect on liver function and high safety.

参考文献/References:

[1] 李艳芳,刘灵军,程 星,等.肝硬化食管静脉曲张破裂出血危险因素分析[J].实用医院临床杂志,2019,16(1):41-44.
[2] Hu T,Stock S,Hong W,et al.Modified sandwich injection with or without ligation for variceal bleeding in patients with both esophageal and gastric varices:A retrospective cohort study[J].Scand J Gastroenterol,2020,55(10):1219-1224.
[3] 裴仁广,汪国祥,王 勇,等.经颈静脉肝内门腔静脉分流术治疗门静脉高压症并发症的疗效分析[J].皖南医学院学报,2022,41(4):351-353.
[4] 曹莉明,张勇学,梁志会,等.经皮肝穿刺胃冠状静脉栓塞术联合肝动脉化疗栓塞术治疗肝癌合并门静脉高压致上消化道出血的临床效果[J].临床误诊误治,2022,35(6):64-68.
[5] Paleti S,Nutalapati V,Fathallah J,et al.Balloon-occluded retrograde transvenous obliteration(BRTO)versus transjugular intrahepatic portosystemic shunt(TIPS)for treatment of gastric varices because of portal hypertension:A systematic review and meta-analysis[J].J Clin Gastroenterol,2020,54(7):655-660.
[6] 周婷婷,潘 月,李珍艳,等.经颈内静脉肝内门腔静脉分流术治疗门静脉高压伴食管胃底静脉曲张破裂出血的临床疗效[J].四川医学,2019,40(6):571-574.
[7] 中华医学会外科学分会脾及门静脉高压外科学组.肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J].中华外科杂志,2019,57(12):885-892.
[8] 中华医学会消化内镜学分会.食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年)[J].中华消化内镜杂志,2004,21(3):149-151.
[9] 中华医学会外科学分会脾及门静脉高压外科学组.肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J].中华消化外科杂志,2019,18(12):1087-1093.
[10] 高淑娟,张 蓉,郭雪艳,等.门脉CT血管成像联合内镜治疗肝硬化食管胃静脉曲张应用价值研究[J].陕西医学杂志,2021,50(7):807-810.
[11] 袁 霞,农 军,陈瑞玲,等.Fibro Touch在安络化纤丸联合富马酸替诺福韦二吡呋酯片治疗乙肝肝硬化代偿期疗效评价中的应用[J].陕西中医,2021,42(S1):84-85.
[12] Liu J,Ma J,Yang C,et al.Sarcopenia in patients with cirrhosis after transjugular intrahepatic portosystemic shunt placement[J].Radiology,2022,303(3):711-719.
[13] 王 云,陈 倩,望荣华,等.肝硬化食管胃静脉曲张的内镜诊治进展[J].内科急危重症杂志,2019,25(1):15-18.
[14] Alqahtani SA,Jang S.Pathophysiology and management of variceal bleeding[J].Drugs,2021,81(6):647-667.
[15] 孙世蒙,牟玉珍,于海东,等.基于门静脉压力梯度等多因素的肝硬化门静脉高压食管静脉曲张破裂出血风险评估初步探讨[J].介入放射学杂志,2020,29(8):807-810.
[16] Zhou GP,Jiang YZ,Sun LY,et al.Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding:A systematic review and meta-analysis[J].Eur Radiol,2021,31(7):5390-5399.
[17] Ji K,Li X,Zhu H,et al.A creatinine-based model for predicting recurrent bleeding after modified percutaneous transhepatic variceal embolization in patients with cirrhosis[J].J Interv Med,2022,5(2):95-102.
[18] 熊超杰,虞哲伟,胡杨科,等.肝移植术中脾动脉结扎对肝功能恢复及脾功能亢进的影响[J].中华普通外科杂志,2020,35(7):516-520.
[19] 黄 山,姚 欣,陈雪玲,等.早期经颈静脉肝内门体分流术治疗老年肝硬化食管静脉曲张破裂出血的临床研究[J].现代消化及介入诊疗,2021,26(2):197-201,207.
[20] 张晓丰,张 玮,于之源,等.经颈静脉肝内门体分流术后分流道失功再通肝硬化患者预后影响因素分析[J].临床肝胆病杂志,2020,36(2):338-342.

相似文献/References:

[1]王小芳,张利军.可溶性人髓系细胞触发受体1、可溶性血红蛋白清道夫受体、降钙素原表达水平对肝硬化合并自发性细菌性腹膜炎的诊断价值[J].陕西医学杂志,2021,50(12):1525.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.014]
[2]郭武辉,张 华.血清T淋巴细胞亚群检测在肝硬化合并真菌性血流感染中的诊断价值[J].陕西医学杂志,2021,50(12):1570.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.026]
　GUO Wuhui,ZHANG Hua.Diagnostic value of serum T lymphocyte subsets detection in liver cirrhosis complicated with fungal bloodstream infection[J].,2021,50(9):1570.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.026]
[3]樊江浩,王 嘉,万 杰,等.肝硬化门静脉血栓抗凝治疗有效性及安全性Meta分析[J].陕西医学杂志,2023,52(4):487.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.028]
　FAN Jianghao,WANG Jia,WAN Jie,et al.Efficacy and safety of anticoagulant therapy for portal vein thrombosis in liver cirrhosis:a meta-analysis[J].,2023,52(9):487.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.028]
[4]杨金艳,李飞飞,谢元元,等.肝硬化上消化道出血患者预后营养指数与病情严重程度和短期预后相关性研究[J].陕西医学杂志,2023,52(11):1530.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.017]
[5]王 婷,邹百仓,董 蕾,等.核苷类似物治疗乙型肝炎肝硬化并发食管静脉曲张临床价值研究[J].陕西医学杂志,2024,(5):671.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.021]
　WANG Ting,ZOU Baicang,DONG Lei,et al.Value of nucleoside analogues in the treatment of hepatitis B cirrhosis complicated with esophageal varices[J].,2024,(9):671.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.021]

备注/Memo

备注/Memo:
基金项目:四川省医学科研课题(S18014)
更新日期/Last Update: 2023-09-04